Cramer | Buy

: Praised for its robust drug pipeline and use of AI in cancer treatments.

: There is a documented increase in short-selling activity immediately following his buy recommendations as professional investors exploit the temporary overpricing. Recent "Buy" Recommendations (April 2026) cramer buy

: Identified as an undervalued player shifting into high-growth services. : Praised for its robust drug pipeline and

and Amazon (AMZN) : Labeled as "undervalued" trillion-dollar AI opportunities. Infrastructure & Energy : and Amazon (AMZN) : Labeled as "undervalued" trillion-dollar

: Cited for its strong position as rivals scale back.

Several academic papers have analyzed the effectiveness of Cramer’s picks on CNBC's Mad Money :

Academic research and recent market analysis of Jim Cramer’s "Buy" recommendations consistently highlight a phenomenon known as the where stock prices rise immediately after a mention but often reverse in the following weeks. Market Impact Findings